ReviewDiseases (Basel, Switzerland)2025

Emerging Clinical Role of Tavapadon, a Novel Dopamine Partial Agonist, in the Treatment of Parkinson's Disease.

Alan D Kaye et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.